Four of five top-ranked health plans operate in Mass., NCQA says
The National Committee on Quality Assurance has released a new ranking of nearly 500 private health insurance plans.
The National Committee on Quality Assurance (NCQA) has released a new evaluation of more than 500 private health plans, ranking 474 of them based on clinical performance, member satisfaction, and NCQA accreditation.
Eligibility for the rankings depended on each health plan’s public release of performance information and the submission of enough data for statistically valid analysis, according to NCQA. The top 10 health plans:
1. Harvard Pilgrim Health Care - HMO/POS (Massachusetts, Maine)
2. Tufts Associated Health Maintenance Organization - HMO/POS (Massachusetts)
3. Capital Health Plan - HMO (Florida)
4. Tufts Benefit Administrators - PPO (Massachusetts, Rhode Island)
5. Harvard Pilgrim Health Care - PPO (Massachusetts)
6. Kaiser Foundation Health Plan of Colorado - HMO (Colorado)
7. Harvard Pilgrim Health Care of New England - HMO/POS (New Hampshire)
8. Kaiser Foundation Health Plan of Northern California - HMO (California)
9. Group Health Cooperative of South Central Wisconsin - HMO (Wisconsin)
10. Kaiser Foundation Health Plan of Southern California - HMO (California)
Click here to see a full, detailed list of NCQA’s new rankings.
Unrealistic Portrayals of Cardiac Arrest in Contemporary Film | ACC 2025
March 31st 2025Cardiac arrests in contemporary film are largely inaccurate when it comes to survival rate and etiology, according to a poster presented today at the American College of Cardiology conference held March 29 to 31 in Chicago.
Read More
Breaking Down Health Plans, HSAs, AI With Paul Fronstin of EBRI
November 19th 2024Featured in this latest episode of Tuning In to the C-Suite podcast is Paul Fronstin, director of health benefits research at EBRI, who shed light on the evolving landscape of health benefits with editors of Managed Healthcare Executive.
Listen
In this latest episode of Tuning In to the C-Suite podcast, Briana Contreras, an editor with MHE had the pleasure of meeting Loren McCaghy, director of consulting, health and consumer engagement and product insight at Accenture, to discuss the organization's latest report on U.S. consumers switching healthcare providers and insurance payers.
Listen
Winrevair Reduced Risk of Morbidity and Mortality by 76% in PAH | ACC 2025
March 31st 2025In the ZENITH trial, Winrevair was evaluated based on a composite endpoint of all-cause death, lung transplantation or disease-related hospitalization for patients with pulmonary arterial hypertension.
Read More
Clopidogrel Beat Aspirin in Preventing Heart Attacks After PCI | ACC 2025
March 31st 2025Clopidogrel monotherapy may be an alternative to aspirin for prevention of cardiac events in high-risk patients after percutaneous coronary intervention, according to a new study presented at ACC 2025.
Read More
